FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Publications
  • Links
  • News
✕

Academia Ophthalmologica Internationalis: Prof. Cursiefen new member

Claus Cursiefen

Univ.-Prof. Dr. Claus Cursiefen, Director of the Center for Ophthalmology at the University Hospital of Cologne and the Faculty of Medicine, has been elected to Chair LVI of the international university ophthalmological association at the annual meeting of the Academia Ophthalmologica Internationalis (AOI) in Prague.

Active membership is limited to 100 chairs, each of which is assigned a Roman numeral from I to C. Currently, AOI active and emeritus members represent 33 countries around the world. “Being appointed to the prestigious Academia is a great honor and at the same time a task to increase our commitment to the international fight against blindness,” said Prof. Cursiefen. The association advocates for excellence in education, research and medical care worldwide to preserve and restore sight to people around the world.

Worldwide, 36 million people are blind, and another 217 million suffer from moderate or severe visual impairment. Forecasts predict that blindness and severe visual impairment will increase sharply in the coming years. To address this problem, Academia Ophthalmologica Internationalis, the International Council of Ophthalmology, and representatives of ophthalmology organizations and industry have formulated the International Ophthalmology Strategic Plan to “Preserve and Restore Vision – Vision for the Future.” This joint effort is supported by the Ophthalmology Foundation and is closely related to the Global Initiative to Eliminate Preventable Blindness. The Vision 2020 – The Right to Sight Initiative, is a multi-year program supported by the World Health Organization and the International Agency for the Prevention of Blindness.

Related posts

April 23, 2025

SFB 1607 Launches Website and Celebrates TEO-C New Lab Location


Read more
April 23, 2025

New SFB 1607 Launched – Building on the Foundations of FOR2240


Read more

Fakultaetspreise 2024

February 27, 2024

Faculty prize for PD Dr. Schrittenlocher – Awarded for best habilitation in 2022


Read more

News

  • SFB 1607 Launches Website and Celebrates TEO-C New Lab Location
  • New SFB 1607 Launched – Building on the Foundations of FOR2240
  • Faculty prize for PD Dr. Schrittenlocher – Awarded for best habilitation in 2022
  • DOG poster award for Dr. Martina Maaß
  • Young Cologne Eye Researcher Šejla Gegić won Margarete Kramer Prize

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Claudia Bock
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
claudia.bock@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck
      Um unsere Website für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies und insb. der Möglichkeiten, der Verwendung von Cookies zu widersprechen, erhalten Sie in unserer Datenschutzerklärung.SchließenDatenschutzerklärung